UBS Group’s AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF DECU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-60
Closed -$1.59K 11309
2026
Q1
$1.59K Buy
+60
New +$1.64K ﹤0.01% 9483
2025
Q4
Sell
-1,402
Closed -$37.7K 11407
2025
Q3
$37.7K Buy
+1,402
New +$36.5K ﹤0.01% 7760
2025
Q2
Sell
-1,702
Closed -$40.9K 11068
2025
Q1
$40.9K Buy
1,702
+1,406
+475% +$34.7K ﹤0.01% 7727
2024
Q4
$7.27K Buy
+296
New +$7.39K ﹤0.01% 8489

Other funds holding DECU

UBS Group's DECU Position: Q2 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF (DECU) in Q2 2026, closing a stake of 60 shares — an estimated $1.59K sold.

UBS Group first reported a position in DECU in Q4 2024 and held it in 4 quarters. The position peaked at $40.9K in Q1 2025. 38 funds tracked by Wall St. Rank hold DECU as of Q2 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 60 AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF shares in Q2 2026, an estimated $1.59K.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF in Q4 2024 and held it in 4 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF position peaked at $40.9K in Q1 2025.
  • 38 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer15 Uncapped Dec ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.